| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA906: Rimegepant for preventing episodic migraine |
|
Medicine details |
|
| Medicine name | rimepagent (Vydura®) |
| Formulation | oral |
| Reference number | 5281 |
| Indication | For preventing episodic migraine |
| Company | Pfizer Ltd |
| BNF chapter | Central nervous system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 31/05/2023 |
| NICE guidance | |